| Issue |
Section |
Title |
File |
| Vol 9, No 3 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
THE FIRST RESULTS OF TARGETED THERAPY FOR KIDNEY CANCER IN MOSCOW |
(Rus)
|
| Vol 11, No 2 (2015) |
PROSTATE CANCER |
Experience with octreotide depot in the treatment of castration-resistant prostate cancer |
(Rus)
|
| Vol 11, No 3 (2015) |
PROSTATE CANCER |
Buserelin-depot in the treatment of prostate cancer |
(Rus)
|
| Vol 12, No 3 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Results and analysis of the application of a consistent targeted therapy in patients with metastatic renal cell carcinoma in Moscow (for the period from June 2005 to July 2015) |
(Rus)
(Eng)
|
| Vol 12, No 2 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Interim results of targeted therapy of patients with metastatic kidney cancer in Moscow (for the period from June 2005 to July 2015) |
(Rus)
(Eng)
|
| Vol 12, No 2 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficiency and safety of the everolimus in patients with the generalized renal cell carcinoma (multicentral observational study) |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
PROSTATE CANCER |
Somatostatin analogs in the treatment of castrate-resistant prostate cancer: efficacy and tolerability |
(Rus)
(Eng)
|
| Vol 12, No 3 (2016) |
CONGRESSES AND CONFERENCES |
Resolution on the results of the Meeting of Experts on the treatment of castrate-resistant prostate cancer |
(Rus)
|
| Vol 14, No 3 (2018) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM |
(Rus)
|
| Vol 17, No 1 (2021) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study |
(Rus)
|
